GLP1R and obesity due to melanocortin 4 receptor deficiency: Medications that act on GLP-1 receptors are known as GLP-1 receptor agonists (GLP-1RAs), and they primarily include injectable and oral agents designed to treat type 2 diabetes and obesity by mimicking the effects of endogenous GLP-1 hormone.